Lataa...
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis
BACKGROUND: Natalizumab (NTZ) is sometimes discontinued in patients with multiple sclerosis, mainly due to concerns about the risk of progressive multifocal leukoencephalopathy. However, NTZ interruption may result in recrudescence of disease activity. OBJECTIVE: The objective of this study was to s...
Tallennettuna:
| Julkaisussa: | Ther Adv Neurol Disord |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6444403/ https://ncbi.nlm.nih.gov/pubmed/30956686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419837809 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|